North America Monoclonal Antibodies In Veterinary Health Market Size, Share & Industry Analysis Report By Animal Type (Dogs and Other Animal Type), By Scope (Dermatology, Pain, and Other Scope), By End User (Veterinary Hospitals and Other End User), By Country and Growth Forecast, 2025 - 2032

The North America Monoclonal Antibodies In Veterinary Health Market would witness market growth of 18.0% CAGR during the forecast period (2025-2032).

The US market dominated the North America Monoclonal Antibodies In Veterinary Health Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $1,355.6 million by 2032. The Canada market is experiencing a CAGR of 21.1% during (2025 - 2032). Additionally, The Mexico market would exhibit a CAGR of 19.7% during (2025 - 2032).

One of the most prominent trends in the North American veterinary monoclonal antibody (mAb) market is the surge in precision-based therapies targeting specific conditions in companion animals. Pet owners and veterinarians alike are increasingly turning to biologics due to their ability to offer long-lasting, targeted relief with fewer systemic side effects. Monoclonal antibodies designed to address chronic pain, inflammation, and allergic reactions in dogs and cats are gaining popularity, especially as they offer an alternative to traditional treatments like steroids and NSAIDs.

These therapies provide not only enhanced efficacy but also improved safety, leading to broader adoption in routine veterinary practice. Another key trend is the growing emphasis on regulatory oversight and product safety, which is shaping how mAbs are developed, approved, and monitored post-launch. Regulatory bodies have implemented strict guidelines that demand comprehensive safety, purity, and efficacy data. This high standard ensures that only well-tested and thoroughly evaluated biologics reach the market.

The United States dominates the North American veterinary monoclonal antibody (mAb) market, driven by a large and affluent companion animal population, robust veterinary infrastructure, and early regulatory support for biologics. Pet ownership trends mirror human trends of "pet humanization," with owners increasingly willing to invest in high‑end, targeted mAb treatments for chronic pain, dermatological conditions, and cancers. The presence of advanced referral veterinary hospitals, national bodies like the FDA and USDA that oversee veterinary biologics, and favorable reimbursement via rising pet insurance have created a fertile ground for mAb adoption.

Canada is positioned as a strong secondary market following the U.S. in North America’s veterinary monoclonal antibody landscape. While its companion animal market is smaller, it mirrors similar trends of pet humanization and premium product uptake. Veterinary spending is high relative to population and growing steadily, supported by supportive regulation from the Canadian Food Inspection Agency (CFIA) and Health Canada. The country benefits from proximity to the U.S., facilitating parallel product approvals and introductions.

Mexico represents an emerging market for veterinary monoclonal antibodies, marked by a sharp contrast between limited access and rising demand within affluent urban segments. Pet ownership is increasing in large cities like Mexico City, Guadalajara, and Monterrey, fueled by a growing middle class and changing views on pet care. However, the cost sensitivity of most consumers, coupled with limited regulatory experience for biologics in veterinary medicine, slows mAb adoption. Thus, North America continues to lead in veterinary monoclonal antibody innovation, driven by strong R&D infrastructure, high pet healthcare spending, and a favorable regulatory environment.

Free Valuable Insights: The Monoclonal Antibodies In Veterinary Health Market is Predict to reach USD 4.33 Billion by 2032, at a CAGR of 18.5%

Based on Animal Type, the market is segmented into Dogs and Other Animal Type. Based on Scope, the market is segmented into Dermatology, Pain, and Other Scope. Based on End User, the market is segmented into Veterinary Hospitals and Other End User. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Zoetis, Inc.
• Virbac
• Merck KGaA
• Elanco Animal Health, Inc.
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Phibro Animal Health Corporation
• Indian Immunologicals Ltd.

North America Monoclonal Antibodies In Veterinary Health Market Report Segmentation

By Animal Type

• Dogs
• Other Animal Type

By Scope

• Dermatology
• Pain
• Other Scope

By End User

• Veterinary Hospitals
• Other End User

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Monoclonal Antibodies In Veterinary Health Market, by Animal Type
1.4.2 North America Monoclonal Antibodies In Veterinary Health Market, by Scope
1.4.3 North America Monoclonal Antibodies In Veterinary Health Market, by End User
1.4.4 North America Monoclonal Antibodies In Veterinary Health Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Value Chain Analysis of Monoclonal Antibodies In Veterinary Health Market
4.1 Research & Development (R&D)
4.2 Regulatory & Clinical Trials
4.3 Technology Transfer & Process Validation
4.4 Manufacturing
4.5 Packaging & Distribution
4.6 Marketing & Veterinary Engagement
4.7 Post-Market Surveillance & Pharmacovigilance
4.8 Customer Feedback & Support

Chapter 5. Key Costumer Criteria - Monoclonal Antibodies In Veterinary Health Market

Chapter 6. North America Monoclonal Antibodies In Veterinary Health Market by Animal Type
6.1 North America Dogs Market by Region
6.2 North America Other Animal Type Market by Region

Chapter 7. North America Monoclonal Antibodies In Veterinary Health Market by Scope
7.1 North America Dermatology Market by Country
7.2 North America Pain Market by Country
7.3 North America Other Scope Market by Country

Chapter 8. North America Monoclonal Antibodies In Veterinary Health Market by End User
8.1 North America Veterinary Hospitals Market by Country
8.2 North America Other End User Market by Country

Chapter 9. North America Monoclonal Antibodies In Veterinary Health Market by Country
9.1 US Monoclonal Antibodies In Veterinary Health Market
9.1.1 US Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.1.2 US Monoclonal Antibodies In Veterinary Health Market by Scope
9.1.3 US Monoclonal Antibodies In Veterinary Health Market by End User
9.2 Canada Monoclonal Antibodies In Veterinary Health Market
9.2.1 Canada Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.2.2 Canada Monoclonal Antibodies In Veterinary Health Market by Scope
9.2.3 Canada Monoclonal Antibodies In Veterinary Health Market by End User
9.3 Mexico Monoclonal Antibodies In Veterinary Health Market
9.3.1 Mexico Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.3.2 Mexico Monoclonal Antibodies In Veterinary Health Market by Scope
9.3.3 Mexico Monoclonal Antibodies In Veterinary Health Market by End User
9.4 Rest of North America Monoclonal Antibodies In Veterinary Health Market
9.4.1 Rest of North America Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.4.2 Rest of North America Monoclonal Antibodies In Veterinary Health Market by Scope
9.4.3 Rest of North America Monoclonal Antibodies In Veterinary Health Market by End User

Chapter 10. Company Profiles
10.1 Zoetis, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.6 SWOT Analysis
10.2 Virbac
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Recent strategies and developments:
10.2.4.1 Partnerships, Collaborations, and Agreements:
10.2.5 SWOT Analysis
10.3 Merck KGaA
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 SWOT Analysis
10.4 Elanco Animal Health, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 SWOT Analysis
10.5 Boehringer Ingelheim International GmbH
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 SWOT Analysis
10.6 Ceva Sante Animale
10.6.1 Company Overview
10.6.2 SWOT Analysis
10.7 Phibro Animal Health Corporation
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.8 Indian Immunologicals Ltd.
10.8.1 Company Overview

TABLE 1 North America Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 2 North America Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 3 Key Costumer Criteria - Monoclonal Antibodies In Veterinary Health Market
TABLE 4 North America Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 5 North America Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 6 North America Dogs Market by Region, 2021 - 2024, USD Million
TABLE 7 North America Dogs Market by Region, 2025 - 2032, USD Million
TABLE 8 North America Other Animal Type Market by Region, 2021 - 2024, USD Million
TABLE 9 North America Other Animal Type Market by Region, 2025 - 2032, USD Million
TABLE 10 Use Case 1: Canine Monoclonal Antibody Therapies – Targeted Treatment Innovations for Dogs
TABLE 11 Use Case 2: Monoclonal Antibodies for Livestock & Exotic Animals – Immune-Driven Disease Control
TABLE 12 North America Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 13 North America Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 14 North America Dermatology Market by Country, 2021 - 2024, USD Million
TABLE 15 North America Dermatology Market by Country, 2025 - 2032, USD Million
TABLE 16 North America Pain Market by Country, 2021 - 2024, USD Million
TABLE 17 North America Pain Market by Country, 2025 - 2032, USD Million
TABLE 18 North America Other Scope Market by Country, 2021 - 2024, USD Million
TABLE 19 North America Other Scope Market by Country, 2025 - 2032, USD Million
TABLE 20 Use Case 1: Targeted Monoclonal Antibody Therapy for Canine Dermatological Conditions
TABLE 21 Use Case 2: Monoclonal Antibody-Based Pain Management in Veterinary Orthopedic Care
TABLE 22 Use Case 3: Monoclonal Antibodies for Veterinary Oncology, Immune Modulation & Infectious Disease
TABLE 23 North America Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 24 North America Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 25 North America Veterinary Hospitals Market by Country, 2021 - 2024, USD Million
TABLE 26 North America Veterinary Hospitals Market by Country, 2025 - 2032, USD Million
TABLE 27 North America Other End User Market by Country, 2021 - 2024, USD Million
TABLE 28 North America Other End User Market by Country, 2025 - 2032, USD Million
TABLE 29 North America Monoclonal Antibodies In Veterinary Health Market by Country, 2021 - 2024, USD Million
TABLE 30 North America Monoclonal Antibodies In Veterinary Health Market by Country, 2025 - 2032, USD Million
TABLE 31 US Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 32 US Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 33 US Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 34 US Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 35 US Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 36 US Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 37 US Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 38 US Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 39 Canada Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 40 Canada Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 41 Canada Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 42 Canada Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 43 Canada Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 44 Canada Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 45 Canada Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 46 Canada Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 47 Mexico Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 48 Mexico Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 49 Mexico Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 50 Mexico Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 51 Mexico Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 52 Mexico Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 53 Mexico Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 54 Mexico Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 55 Rest of North America Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 56 Rest of North America Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 57 Rest of North America Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 58 Rest of North America Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 59 Rest of North America Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 60 Rest of North America Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 61 Rest of North America Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 62 Rest of North America Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 63 Key Information – Zoetis, Inc.
TABLE 64 Key Information – Virbac
TABLE 65 key Information – Merck KGaA
TABLE 66 Key information – Elanco Animal Health, Inc.
TABLE 67 Key Information – Boehringer Ingelheim International GmbH
TABLE 68 Key Information – Ceva SantE Animale
TABLE 69 Key Information – Phibro Animal Health Corporation
TABLE 70 Key Information – Indian Immunologicals Ltd

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Monoclonal Antibodies In Veterinary Health Market, 2021 - 2032, USD Million
FIG 3 Key Factors Impacting Monoclonal Antibodies In Veterinary Health Market
FIG 4 Porter’s Five Forces Analysis – Monoclonal Antibodies In Veterinary Health Market
FIG 5 Value Chain Analysis of Monoclonal Antibodies In Veterinary Health Market
FIG 6 Key Costumer Criteria - Monoclonal Antibodies In Veterinary Health Market
FIG 7 North America Monoclonal Antibodies In Veterinary Health Market share by Animal Type, 2024
FIG 8 North America Monoclonal Antibodies In Veterinary Health Market share by Animal Type, 2032
FIG 9 North America Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2032, USD Million
FIG 10 North America Monoclonal Antibodies In Veterinary Health Market share by Scope, 2024
FIG 11 North America Monoclonal Antibodies In Veterinary Health Market share by Scope, 2032
FIG 12 North America Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2032, USD Million
FIG 13 North America Monoclonal Antibodies In Veterinary Health Market share by End User, 2024
FIG 14 North America Monoclonal Antibodies In Veterinary Health Market share by End User, 2032
FIG 15 North America Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2032, USD Million
FIG 16 North America Monoclonal Antibodies In Veterinary Health Market share by Country, 2024
FIG 17 North America Monoclonal Antibodies In Veterinary Health Market share by Country, 2032
FIG 18 North America Monoclonal Antibodies In Veterinary Health Market by Country, 2021 - 2032, USD Million
FIG 19 Swot Analysis: ZOETIS, INC.
FIG 20 SWOT Analysis: Virbac
FIG 21 Swot Analysis: Merck KGaA
FIG 22 SWOT Analysis: Elanco Animal Health, Inc.
FIG 23 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 24 SWOT Analysis: Ceva Sante Animale